Drugs / Hirudoid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07388927 | Feb → Mar 2026 overdue | disease of orbital part of eye adnexa | DKSH Management (Thailand) Limited | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hirudoid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07388927 ↗ |
| Route | Topical | “Hirudoid is a topical treatment that is indicated for the soothing relief of superficial bruising and haematoma.” NCT07388927 ↗ |